PRICE Act

The PRICE Act, also known as Bill 118 s 3264, is a piece of legislation currently being considered by the US Congress. The purpose of this bill is to address the issue of prescription drug pricing and affordability in the United States.

The PRICE Act aims to increase transparency in the pharmaceutical industry by requiring drug manufacturers to provide detailed information on the costs associated with producing and marketing their products. This information would be made publicly available in order to give consumers and policymakers a better understanding of how drug prices are determined.

Additionally, the PRICE Act seeks to promote competition in the pharmaceutical market by allowing for the importation of lower-cost prescription drugs from other countries. This provision is intended to help lower drug prices for American consumers by increasing access to more affordable medications. Furthermore, the PRICE Act includes measures to address the issue of price gouging by pharmaceutical companies. It would require drug manufacturers to justify price increases for certain medications and provide notification to the Department of Health and Human Services before implementing any significant price hikes. Overall, the PRICE Act is aimed at addressing the rising cost of prescription drugs in the United States and ensuring that all Americans have access to affordable medications. It remains to be seen whether this legislation will be passed by Congress and signed into law, but it represents an important step towards addressing the issue of drug pricing in the US.